October 2018
Stock I'm watching this month:-
MYX - Mayne Pharma Group Limited
Sector: Healthcare
Market Cap: 1.84 Billion
Price/Earnings: N/A
Price/Book: 1.49
Return On Equity: -10.54%
Return On Assets: 2.14%
Debt/Equity: 30.3%
Reasons to watch: MYX is a pharmaceutical company, which manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The valuation looks poor; however is currently trading around Morningstar's Fair Value Estimate, and shows good price momentum.
Sentiment: Buy
Disclosure: Held
My Strike Price: Market Price (Morningstar Fair Value: $1.22)
Disclaimer: This does not constitute any financial advice or stock recommendations. As always, Do Your Own Research.
Comments
Post a Comment